Increased levels of HPV16 E6*I transcripts in high-grade cervical cytology and histology (CIN II+) detected by rapid real-time RT-PCR amplification

Cytopathology

Volumn 18, Issue 5, 2007, Pages 290-299

  Kosel S ^a   Burggraf, S ^a   Engelhardt, W ^a   Olgemoller B ^a  

^a Labor Becker   (Germany)

Author keywords

Cervical cancer; Cervical dysplasia; Cytodiagnosis; Diagnosis; Human papillomavirus; Integration of viral DNA; Laboratory diagnosis; Laboratory techniques; Relative quantification

Indexed keywords

MESSENGER RNA; VIRUS DNA; VIRUS RNA;

ADOLESCENT; ADULT; ARTICLE; CANCER DIAGNOSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPATHOLOGY; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA DEGRADATION; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DYSPLASIA; VIRUS CARCINOGENESIS;

ADOLESCENT; ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA, VIRAL; FEMALE; HUMANS; MIDDLE AGED; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; PRECANCEROUS CONDITIONS; PROGNOSIS; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS;

EID: 34748918979     PISSN: 09565507     EISSN: 13652303     Source Type: Journal    
DOI: 10.1111/j.1365-2303.2007.00481.x     Document Type: Article

References (28)

1. Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 2003 88 : 63 73.
2. Munoz N, Bosch FX, de Sanjose S et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003 348 : 518 27.
3. Ratnam S, Franco EL, Ferenczy A. Human papillomavirus testing for primary screening of cervical cancer precursors. Cancer Epidemiol Biomarkers Prev 2000 9 : 945 51.
4. Moscicki AB, Shiboski S, Hills NK et al. Regression of low-grade squamous intra-epithelial lesions in young women. Lancet 2004 364 : 1678 83.
5. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998 338 : 423 8.
6. Bavin PJ, Giles JA, Deery A et al. Use of semi-quantitative PCR for human papillomavirus DNA type 16 to identify women with high grade cervical disease in a population presenting with a mildly dyskaryotic smear report. Br J Cancer 1993 67 : 602 5.
7. Josefsson AM, Magnusson PK, Ylitalo N et al. Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study. Lancet 2000 355 : 2189 93.
8. van Duin M, Snijders PJ, Schrijnemakers HF et al. Human papillomavirus 16 load in normal and abnormal cervical scrapes: an indicator of CIN II/III and viral clearance. Int J Cancer 2002 98 : 590 5.
9. Swan DC, Tucker RA, Tortolero-Luna G et al. Human papillomavirus (HPV) DNA copy number is dependent on grade of cervical disease and HPV type. J Clin Microbiol 1999 37 : 1030 4.
10. Hopman AH, Smedts F, Dignef W et al. Transition of high-grade cervical intraepithelial neoplasia to micro-invasive carcinoma is characterized by integration of HPV 16/18 and numerical chromosome abnormalities. J Pathol 2004 202 : 23 33.
11. Kalantari M, Blennow E, Hagmar B, Johansson B. Physical state of HPV16 and chromosomal mapping of the integrated form in cervical carcinomas. Diagn Mol Pathol 2001 10 : 46 54.
12. Cullen AP, Reid R, Campion M, Lorincz AT. Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm. J Virol 1991 65 : 606 12.
13. Munger K, Howley PM. Human papillomavirus immortalization and transformation functions. Virus Res 2002 89 : 213 28.
14. Sotlar K, Stubner A, Diemer D et al. Detection of high-risk human papillomavirus E6 and E7 oncogene transcripts in cervical scrapes by nested RT-polymerase chain reaction. J Med Virol 2004 74 : 107 16.
15. Lamarcq L, Deeds J, Ginzinger D et al. Measurements of human papillomavirus transcripts by real time quantitative reverse transcription-polymerase chain reaction in samples collected for cervical cancer screening. J Mol Diagn 2002 4 : 97 102.
16. Wang-Johanning F, Lu DW, Wang Y, Johnson MR, Johanning GL. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis. Cancer 2002 94 : 2199 210.
17. Sathish N, Abraham P, Peedicayil A et al. Human papillomavirus 16 E6/E7 transcript and E2 gene status in patients with cervical neoplasia. Mol Diagn 2004 8 : 57 64.
18. Nakagawa S, Yoshikawa H, Yasugi T et al. Ubiquitous presence of E6 and E7 transcripts in human papillomavirus- positive cervical carcinomas regardless of its type. J Med Virol 2000 62 : 251 8.
19. Manos MM, Kinney WK, Hurley LB et al. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA 1999 281 : 1605 10.
20. Kjaer SK, van den Brule AJ, Paull G et al. Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study. BMJ 2002 325 : 572 6.
21. Molden T, Kraus I, Karlsen F et al. Comparison of human papillomavirus messenger RNA and DNA detection: a cross-sectional study of 4,136 women >30 years of age with a 2-year follow-up of high-grade squamous intraepithelial lesion. Cancer Epidemiol Biomarkers Prev 2005 14 : 367 72.
22. Hudelist G, Manavi M, Pischinger KI et al. Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade. Gynecol Oncol 2004 92 : 873 80.
23. Pirami L, Giache V, Becciolini A. Analysis of HPV16, 18, 31, and 35 DNA in pre-invasive and invasive lesions of the uterine cervix. J Clin Pathol 1997 50 : 600 4.
24. Kulmala SM, Syrjanen SM, Gyllensten UB et al. Early integration of high copy HPV16 detectable in women with normal and low grade cervical cytology and histology. J Clin Pathol 2006 59 : 513 7.
25. Ylitalo N, Sorensen P, Josefsson AM et al. Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study. Lancet 2000 355 : 2194 8.
26. Forslund O, Lindqvist P, Haadem K, Czegledy J, Hansson BG. HPV 16 DNA and mRNA in cervical brush samples quantified by PCR and microwell hybridization. J Virol Methods 1997 69 : 209 22.
27. Hsu EM, McNicol PJ, Guijon FB, Paraskevas M. Quantification of HPV-16 E6-E7 transcription in cervical intraepithelial neoplasia by reverse transcriptase polymerase chain reaction. Int J Cancer 1993 55 : 397 401.
28. von Knebel-Doeberitz M, Syrjanen KJ. Molecular markers: how to apply in practice. Gynecol Oncol 2006 103 : 18 20.